Novartis has entered into an agreement to sell 53.3 million (approximately 33%) Roche bearer shares in a bilateral transaction to Roche for a consideration of USD 20.7 billion. Novartis had acquired the stake between 2001 and 2003 for approximately USD 5
Tags :Rolf Watter
AC Immune, a clinical-stage biopharmaceutical precision medicine company for neurodegenerative diseases, announced it’s acquisition of Affiris’s portfolio of therapeutics targeting alphasynuclein (a-syn), notably Affiris PD01, a clinically-validated active vaccine candidate for the treatment
The team includes Urs Kägi (pictured), Rolf Watter, Nadina Duss, Michael Bänziger and Matthias Tanner (all M&A/Corporate and Commercial), Susanne Schreiber (Tax), Lukas Roesler (Finance), Ruth Bloch-Riemer (Social Security), Laura Widmer (
On 10 July 2020, MCH Group announced a comprehensive set of measures, including a new anchor investor, Lupa Systems, an independent private investment company owned by James Murdoch.
Saint-Gobain's subsidiary Schenker-Winkler Holding (SWH) sold its 10.75% stake in Sika for CHF 2.56 billion. The shares were placed via a private placement to qualified institutional investors by way of an accelerated bookbuilding process (ABB).
Approximately 30,000 customers of CSS Versicherung will transfer to Zürich Versicherungs, as well as 68 employees
